On September 29, a critical development surfaced in the world of corporate law when the Supreme Court assented to review a case that might considerably shape the perimeter of corporate liability under the securities laws. The contention arises from the issue of whether the “management’s discussion and analysis” (MD&A) in public companies’ annual reports, which the Securities and Exchange Commission (SEC) necessitates, could serve as grounds for securities-fraud liability. Currently, lower courts exhibit a lack of consensus on this issue; this is exactly what the Supreme Court is set to resolve. Goodwin notes this anticipated judgment.
MD&A is an integral part of a company’s annual report. It seeks to provide a narrative explanation, through the eyes of management, about how a company’s financial performance has fared over the past fiscal year, its current financial condition, and the management’s projection of the company’s future prospects. The goal is to give investors the ability to see the company through the eyes of management.
The issue of securities-fraud liability based on MD&A isn’t new. However, the disagreement among lower courts signifies the legal complexities and uncertainties involved, which the Supreme Court’s ruling is expected to address compellingly. Depending on the Supreme Court’s decision, corporate liability under the securities laws could be either significantly expanded or curtailed.
This case holds utmost significance for legal professionals working in multinational corporations and high-scale law firms. Whichever way the Supreme Court leans could set a far reaching precedent potentially impacting the manner legal experts in the securities field plan their defense strategies, document compliance efforts and navigate reporting procedures. Overall, the case will further set the tone of lawful conduct for corporations in their bids to showcase accurate and transparent financial performance via annual reports.
In response to these situations, corporations and law firms should be proactive to ensure the absolute quality of their MD&A reports and associated disclosures, to alleviate any legal risks or potential claims of securities fraud. An anticipatory attitude, coupled with a keen eye on the developments from the Supreme Court, is the much-needed aspect at present.